Clinical and genetic spectrum of sarcoglycanopathies in a large cohort of Chinese patients

Abstract

This study expands the clinical and genetic spectrum of sarcoglycanopathies in Chinese patients and provides evidence that disease severity of LGMD2D may be predicted by α-sarcoglycan expression and SGCA mutation.